Investors should not expect the same returns in a changing market environment, cautioned Howard Marks, co-founder of Oaktree ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

Explore ongoing trends in the apparel & footwear industries, including brand performance, retail trends, and consumer ...

Petrobras' low-cost operations, quality crude oil and strategic debt reduction enhance its attractiveness for investors. Read ...

Singapore Technologies Engineering Ltd stock is a buy with a raised price target to $38.71, driven by growth and diverse ...

Discover why Sekisui House is an undervalued Japanese home builder with strong growth, international expansion, and ...

Analyst review of AT&T Inc.'s strong Q4 earnings, AI investments, and shareholder returns, suggesting caution due to current ...

Discover how RISR's unique focus on interest-only mortgage-backed securities with a 5.6% yield and negative duration can be ...

Aker BP showed strong operational performance, with record cash flow, low production costs, and efficient project execution.

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

Immutep Limited (IMMP) is a promising biotech stock with a strong pipeline and solid financial foundation, making it a buy ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...